Ki‐Bae Seung - Concepedia

Author

Ki‐Bae Seung

Also Known As

Hyo-Soo Kim, K B Seung, K Seung, K. B. Seung, K. Seung, K.B. Seung, KI‐BAE SEUNG, Ki-Bae Seung, Kibae Seung, Ki‐Bae Seung

232

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

Catholic University of Korea The Catholic University of Korea Seoul St. Mary's Hospital The Catholic University of Korea Uijeongbu St. Mary's Hospital The Catholic University of Korea Incheon St. Mary's Hospital Chonnam National University Hospital

About

Ki‐Bae Seung is an author at Catholic University of Korea specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	33	3.5K
2	Public Health	12	13	1.2K
3	Health Sciences	3	3	269
4	Engineering	2	2	1K
5	Allergy	1	1	1.3K

Ki‐Bae Seung

Publications

6.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial Paul M. Ridker, Jean MacFadyen, Tom Thurén, The Lancet InflammationAllergyLung InflammationMedicineMetronomic Therapy	2017	1.3K
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound Ik‐Kyung Jang, Brett E. Bouma, Dong-Heon Kang, Journal of the American College of Cardiology Coronary Atherosclerotic PlaquesEngineeringVascular ImageCardiovascular DiseaseMedical Imaging	2002	996
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial Paul M. Ridker, Jean MacFadyen, Peter Libby, The Lancet Cardiovascular ToxicityC-reactive Protein ReductionCardiovascular DiseaseCardiovascular PharmacologyEvent Reduction	2017	847
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation Cheol Whan Lee, Jung‐Min Ahn, Duk‐Woo Park, Circulation	2013	278
Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Regulatory T Cell and Macrophage Polarization Eun Ho Choo, Jun‐Ho Lee, Eunhye Park, Circulation	2017	178
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial Chan Joon Kim, Mahn‐Won Park, Min Chul Kim, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineRandomised Trial	2021	177
The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention Yeoree Yang, Tae‐Hoon Kim, Kun‐Ho Yoon, International Journal of Cardiology Metabolic SyndromePercutaneous Coronary InterventionDiabetes ManagementHealth PolicyCardiovascular Disease	2017	162
Comparison of Zotarolimus-Eluting Stents With Sirolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization Duk‐Woo Park, Young‐Hak Kim, Sung‐Cheol Yun, Journal of the American College of Cardiology Percutaneous Coronary InterventionEndovascular TechniqueCardiovascular DiseaseAtherosclerosisPaclitaxel-eluting Stents	2010	149
Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention Eun Ho Choo, Kiyuk Chang, Youngkeun Ahn, Heart	2014	77
Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor Sang‐Hyun Ihm, Kiyuk Chang, Hee-Yeol Kim, Basic Research in Cardiology Metabolic SyndromeCardiomyopathyMedicinePhysiologyDiabetes	2009	76

Page 1